Real-World Evidence and Industry Momentum Builds for iMDx’s Flagship GraftAssure Assay Apr 14, 2026 08:00AM
Needham Reiterates Buy Rating on Insight Molecular Diagnostics Inc. (IMDX) Mar 27, 2026 05:58AM
iMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare Conference Mar 20, 2026 08:00AM
Needham: 'we believe that IMDX is making good progress towards its GraftAssureDx submissions' Jan 5, 2026 12:27PM
Insight Molecular Diagnostics Inc. (IMDX) PT Raised to $9 at Needham Nov 11, 2025 04:51AM


Aug 12, 2025 06:41AM Needham Reiterates Buy Rating on Insight Molecular Diagnostics Inc. (IMDX)
Aug 4, 2025 04:05PM iMDx to Release Second Quarter 2025 Results on August 11, 2025 and Attend Needham Virtual MedTech and Diagnostics Conference